"Ozempic babies" is the nickname for the wave of unexpected pregnancies among women taking GLP-1 medications like semaglutide and tirzepatide. These drugs are not fertility treatments and are not approved to help you conceive. But weight loss and better insulin sensitivity can quietly restart ovulation, and one of the two medications can make birth control pills less reliable, so pregnancy can happen sooner than you planned. Here's what's actually going on, and why it matters that GLP-1s are not considered safe in pregnancy.
Key takeaways
- GLP-1s don't directly boost fertility. They work indirectly, losing weight and improving insulin sensitivity can restore ovulation and more regular cycles, especially with PCOS.
- Tirzepatide can reduce the effectiveness of the pill. Its FDA label advises a backup barrier method (or a non-oral method) for 4 weeks after starting and after each dose increase. Semaglutide's label does not carry this warning.
- A surprise pregnancy is the real risk. Restored ovulation plus less reliable birth control is exactly why "Ozempic babies" happen.
- GLP-1s are not recommended in pregnancy. The FDA label for semaglutide advises stopping at least 2 months before trying to conceive because the drug clears the body slowly.
- This is a conversation to have with a licensed provider before you're trying, not after a positive test.
What are "Ozempic babies"?
"Ozempic babies" is a social-media term for the surprise pregnancies reported by women on GLP-1 medications, including some who had struggled with infertility for years. The name comes from Ozempic, but the phenomenon spans the whole GLP-1 class: semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).
A quick note on names, because it matters for accuracy: only Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management. Ozempic and Mounjaro are approved to treat type 2 diabetes, and their use for weight loss is off-label. None of them is approved as a fertility drug.
Clinicians at UT Southwestern report seeing more of these pregnancies in their OB/GYN and weight-management clinics, and the pattern is consistent enough to have a name. The medication isn't a fertility treatment, but for some women, the body changes it sets in motion can reopen a door they thought was closed. [2]
Can GLP-1s make you more fertile?
Not directly, but they can restore fertility that excess weight or PCOS had suppressed. GLP-1s aren't fertility drugs; their effect on fertility is largely indirect, driven by weight loss and metabolic improvements such as lower insulin and more balanced hormones. [1]
Here's the physiology. Carrying extra fat tissue raises estrogen and, in many women, drives insulin resistance and higher androgen levels, a combination that can disrupt ovulation. When you lose a meaningful amount of weight and your insulin sensitivity improves, that hormonal picture can rebalance: ovulation returns, cycles become more regular, and the odds of conceiving go up. In clinical trials, GLP-1 medications helped patients lose an average of about 15-20% of body weight, which is more than enough to shift reproductive hormones. [2]
The effect is most striking in polycystic ovary syndrome (PCOS), the most common cause of ovulatory infertility. In a large real-world analysis by Epic Research, women with PCOS on a GLP-1 lost a median of 11.5% of body weight versus 1.9% on metformin, and 55.7% lost at least 10% of their body weight compared with 13.7% on metformin. [5] A 2023 meta-analysis of 11 randomized trials found that GLP-1 receptor agonists improved both natural pregnancy rate and menstrual regularity in women with PCOS. [6] For a fuller look at that, see our complete guide to GLP-1s for PCOS.
Why "Ozempic babies" happen, three overlapping reasons
| Reason | What's happening | Who it affects most |
|---|---|---|
| Restored ovulation | Weight loss and better insulin sensitivity restart regular cycles, so you're fertile again, sometimes without realizing it | Women with PCOS, insulin resistance, or higher body weight |
| Less reliable birth control | Tirzepatide can slow stomach emptying enough to lower absorption of the oral pill | Anyone using birth control pills on tirzepatide |
| A "not trying" mindset | After years of low fertility, many aren't using reliable contraception and aren't watching for pregnancy | Women who assumed they couldn't easily conceive |
Does tirzepatide affect birth control?
Yes, this is the piece that surprises people most. The FDA label for tirzepatide (Zepbound, Mounjaro) warns that it can reduce the effectiveness of oral hormonal contraceptives, because slowed gastric emptying can lower how much of the pill your body absorbs. The effect is largest right after you start and after each dose increase. [4]
The label's practical instruction: if you take the pill, either switch to a non-oral method or add a barrier method (like condoms) for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase. [4]
Semaglutide is different, its label does not carry this oral-contraceptive warning. And non-oral methods aren't affected by either drug, because they don't rely on your stomach absorbing a pill.
| Semaglutide (Ozempic, Wegovy) | Tirzepatide (Mounjaro, Zepbound) | |
|---|---|---|
| Reduces the pill's effectiveness? | Not per its FDA label | Yes, per its FDA label |
| Backup birth control needed? | Not for this reason | Yes, 4 weeks after start + after each dose increase |
| Non-oral methods (IUD, implant, ring, patch, injection) | Unaffected | Unaffected |
We cover this in depth, including which methods stay reliable, in tirzepatide and birth control.
Do you need to stop a GLP-1 before pregnancy?
Yes. GLP-1 medications are not recommended during pregnancy, and current guidance is to stop well before you try to conceive, not once you find out.
For semaglutide, the FDA prescribing information is specific: discontinue at least 2 months (about 8 weeks) before a planned pregnancy to account for the drug's long half-life. Semaglutide's half-life is roughly a week, so it stays in your system for about 5 to 7 weeks after your last dose; the two-month buffer adds a safety margin. [3] Tirzepatide clears somewhat faster, but the same "stop ahead of time" principle applies, your provider will set the timing for your specific medication.
Why the caution? These drugs haven't been adequately studied in pregnant women, and animal studies have raised concerns about fetal harm. On top of that, weight loss offers no benefit during pregnancy, pregnancy is a time to gain appropriately, not to lose. [3] For the step-by-step timing, see our washout guide: when to stop semaglutide before trying to conceive.
Stopping isn't always simple, either. Emerging 2025-2026 research suggests women who stop a GLP-1 right before or in early pregnancy may regain weight and face higher risks of complications like gestational diabetes, which is exactly why this should be a planned, provider-guided transition rather than a snap decision. Bring it up before you start trying.
What if you're already pregnant on a GLP-1?
If you take a positive test while on semaglutide or tirzepatide, stop the medication and contact your provider promptly. [1] Don't panic, an unplanned exposure early on isn't a decision you made carelessly, and your clinician can talk you through next steps, monitoring, and how to manage your weight and health through the pregnancy safely. There's also a pregnancy exposure registry that tracks outcomes for women exposed to semaglutide; your provider can tell you about it. [3]
What about safety and side effects?
Beyond pregnancy, GLP-1 medications carry a boxed warning, the FDA's most serious, for the risk of thyroid C-cell tumors. They're not for people with a personal or family history of medullary thyroid carcinoma or MEN 2 (multiple endocrine neoplasia syndrome type 2). [3][4] Other cautions include pancreatitis, gallbladder problems, and significant GI effects like nausea. This isn't the full list, always review the FDA prescribing information for your specific drug and talk to a licensed provider about your history before starting or stopping.
How Elara helps
At Elara, a licensed provider reviews every patient, and for women, that review includes the questions general telehealth often skips: your cycle, PCOS, birth control, and whether pregnancy is on your radar now or later. If you're thinking about conceiving, that shapes the plan from day one, including if and when to pause treatment.
Elara offers compounded semaglutide from $247/month and compounded tirzepatide from $355/month, all-inclusive, the provider visit, your medication, shipping, and ongoing access to our medical team, plus branded options like Wegovy and Zepbound. Cash-pay, no insurance hurdles, all 50 states plus Puerto Rico.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
If weight loss and fertility are both on your mind, the right next step is a conversation, not a guess. **Take Elara's free eligibility check, a licensed provider reviews every patient.** Explore Elara's semaglutide program or tirzepatide program to learn more.
Frequently asked questions
What are "Ozempic babies"?
"Ozempic babies" is the nickname for unexpected pregnancies in women taking GLP-1 medications such as semaglutide or tirzepatide. These drugs aren't fertility treatments, but weight loss and improved insulin sensitivity can restore ovulation, and tirzepatide can make the pill less effective, leading to surprise pregnancies, sometimes after years of low fertility. [1][2]
Can GLP-1s make you more fertile?
Not directly. GLP-1s aren't fertility drugs, but they can restore fertility that weight or PCOS had suppressed. Losing weight and improving insulin sensitivity can restart ovulation and regularize cycles. In women with PCOS, GLP-1 receptor agonists have been shown to improve natural pregnancy rates and menstrual regularity. [1][6]
Do you need to stop a GLP-1 before pregnancy?
Yes. GLP-1s aren't recommended in pregnancy. The FDA label for semaglutide advises stopping at least 2 months (about 8 weeks) before trying to conceive, because the drug clears slowly. Tirzepatide follows the same "stop ahead of time" principle. Plan the timing with your provider before you start trying. [3]
Are "Ozempic babies" safe?
GLP-1s haven't been adequately studied in pregnancy, and animal data raise concerns, so the medication should be stopped once pregnancy is confirmed. If you conceive on a GLP-1, stop it and contact your provider promptly, early unplanned exposure is not a reason to panic, but it does need medical follow-up and monitoring. [1][3]
Can you get pregnant on semaglutide or tirzepatide?
Yes. Both can restore ovulation as you lose weight, and tirzepatide can reduce the effectiveness of oral birth control. If you don't want to conceive, use reliable contraception, and if you take the pill on tirzepatide, add a backup or non-oral method for 4 weeks after starting and after each dose increase. [4]
The bottom line
"Ozempic babies" aren't a mystery, they're the predictable result of two real effects: GLP-1 weight loss can restart ovulation, and tirzepatide can make the pill less reliable. That's a powerful combination if you're hoping to conceive, and a reason for caution if you're not, because these medications are not safe to continue in pregnancy. Whatever your plans, talk to a licensed provider before you start, or before you start trying.
References
- Cleveland Clinic. "Ozempic Babies": How GLP-1 Agonists Affect Fertility. https://health.clevelandclinic.org/ozempic-babies
- UT Southwestern Medical Center. Surprise "Ozempic babies" underscore links between obesity and fertility. https://utswmed.org/medblog/surprise-ozempic-babies-underscore-links-between-obesity-and-fertility/
- U.S. Food and Drug Administration. WEGOVY (semaglutide) injection, Highlights of Prescribing Information (Pregnancy; Boxed Warning). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
- U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, Prescribing Information (Drug Interactions: oral hormonal contraceptives; Boxed Warning). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806Orig1s020lbl.pdf
- Epic Research. GLP-1s Lead to Greater Weight Loss and A1C Improvement Than Metformin in Patients with PCOS. https://www.epicresearch.org/articles/glp-1s-lead-to-greater-weight-loss-and-a1c-improvement-than-metformin-in-patients-with-pcos/
- Wang J, et al. Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. BMC Endocrine Disorders (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10631119/
This article is for general education and is not medical advice. Talk to a licensed clinician about your situation.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.